• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者的心血管结局:一项回顾性队列研究。

Cardiovascular outcomes in Parkinson's disease patients from a retrospective cohort study.

机构信息

Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.

Department of Biostatistics, Korea University College of Medicine, Seoul, Republic of Korea.

出版信息

Sci Rep. 2024 Sep 20;14(1):21928. doi: 10.1038/s41598-024-72549-y.

DOI:10.1038/s41598-024-72549-y
PMID:39304675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11415384/
Abstract

Parkinson's disease (PD) reports high rates of morbidity and mortality, but the risk of adverse cardiovascular outcomes in patients with PD has not been fully elucidated. This bi-center retrospective cohort study using the electronic health records (EHR) database of two tertiary hospitals screened a total of 327,292 subjects who visited the outpatient clinic, and 1194 patients with PD were propensity score-matched with a control population. The primary outcome was the occurrence of major adverse cardiovascular events (MACE). Key secondary outcomes included all-cause death, cardiovascular (CV) death, stroke, myocardial infarction (MI), heart failure hospitalization and 30-day CV death. After PS matching, MACE occurrence was not significantly different between PD and non-PD groups (18.2% vs. 17.5%, log-rank p = 0.98). Key secondary outcomes were also similar between the two groups. In patients with PD, MACE rate, and also CV risk score, were higher in patients with more severe PD (according to Hoehn and Yahr scale and unified Parkinson's disease rating scale), and after multivariable analysis, PD severity was not an independent predictor of MACE. Patients with PD are at an increased risk of adverse cardiovascular outcomes, but the contribution from other common CV risk factors cannot be ignored. The management of prevalent CV risk factors is therefore important in mitigating adverse outcomes among patients with PD.

摘要

帕金森病(PD)报告的发病率和死亡率较高,但 PD 患者发生不良心血管结局的风险尚未完全阐明。本研究使用两家三级医院的电子健康记录(EHR)数据库进行了一项回顾性队列研究,共筛选了 327292 名门诊就诊患者,其中 1194 名 PD 患者与对照组进行了倾向评分匹配。主要结局是主要不良心血管事件(MACE)的发生。关键次要结局包括全因死亡、心血管(CV)死亡、中风、心肌梗死(MI)、心力衰竭住院和 30 天 CV 死亡。PS 匹配后,PD 组和非 PD 组的 MACE 发生率无显著差异(18.2% vs. 17.5%,log-rank p=0.98)。两组关键次要结局也相似。在 PD 患者中,MACE 发生率以及 CV 风险评分在 Hoehn 和 Yahr 量表和统一帕金森病评定量表评分较高的患者中更高,多变量分析后,PD 严重程度不是 MACE 的独立预测因素。PD 患者发生不良心血管结局的风险增加,但不能忽视其他常见 CV 危险因素的作用。因此,管理常见的 CV 危险因素对于减轻 PD 患者的不良结局很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a33/11415384/e59a48845c3e/41598_2024_72549_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a33/11415384/037438e8ec46/41598_2024_72549_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a33/11415384/e59a48845c3e/41598_2024_72549_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a33/11415384/037438e8ec46/41598_2024_72549_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a33/11415384/e59a48845c3e/41598_2024_72549_Fig2_HTML.jpg

相似文献

1
Cardiovascular outcomes in Parkinson's disease patients from a retrospective cohort study.帕金森病患者的心血管结局:一项回顾性队列研究。
Sci Rep. 2024 Sep 20;14(1):21928. doi: 10.1038/s41598-024-72549-y.
2
Risk of major adverse cardiovascular events in rural vs urban settings among patients with erectile dysfunction: a propensity-weighted retrospective cohort study of 430 621 men.城乡环境下勃起功能障碍患者主要不良心血管事件风险:430621 例男性患者的倾向评分加权回顾性队列研究。
J Sex Med. 2024 May 28;21(6):522-528. doi: 10.1093/jsxmed/qdae043.
3
Matched Cohort Analysis of Total Hip Arthroplasty in Patients With and Without Parkinson's Disease: Complications, Mortality, Length of Stay, and Hospital Charges.伴有和不伴有帕金森病的全髋关节置换术患者的匹配队列分析:并发症、死亡率、住院时间和住院费用。
J Arthroplasty. 2019 Jul;34(7S):S228-S231. doi: 10.1016/j.arth.2019.03.023. Epub 2019 Mar 14.
4
Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease:: A Population-Based Retrospective Cohort Study.肥胖合并心血管疾病患者的减重手术与心血管结局:一项基于人群的回顾性队列研究。
Circulation. 2021 Apr 13;143(15):1468-1480. doi: 10.1161/CIRCULATIONAHA.120.052386. Epub 2021 Apr 5.
5
The Role of Electrochemical Skin Conductance as a Screening Test of Cardiovascular Autonomic Neuropathy in Patients with Parkinson's Disease.电化学皮肤传导作为帕金森病患者心血管自主神经病变筛查试验的作用。
Int J Environ Res Public Health. 2020 Oct 23;17(21):7751. doi: 10.3390/ijerph17217751.
6
Restricted Mean Survival Time Analysis to Estimate SGLT2i-Associated Heterogeneous Treatment Effects on Primary and Secondary Prevention of Cardiorenal Outcomes in Patients With Type 2 Diabetes in Taiwan.限制平均生存时间分析估计 SGLT2i 在台湾 2 型糖尿病患者主要和次要心血管肾脏结局预防中的异质性治疗效果。
JAMA Netw Open. 2022 Dec 1;5(12):e2246928. doi: 10.1001/jamanetworkopen.2022.46928.
7
Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.老年和年轻帕金森病患者接受脑深部电刺激治疗的比较:长达 7 年的随访的长期结果。
J Neurosurg. 2018 Sep 28;131(3):807-812. doi: 10.3171/2018.4.JNS171909. Print 2019 Sep 1.
8
Mortality and morbidity after spinal surgery in patients with Parkinson's disease: a retrospective matched-pair cohort study.帕金森病患者脊柱手术后的死亡率和发病率:一项回顾性配对队列研究。
Spine J. 2017 Apr;17(4):531-537. doi: 10.1016/j.spinee.2016.10.024. Epub 2016 Nov 21.
9
Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study.帕金森病患者肌少症和衰弱的患病率及相关因素:一项横断面研究。
Gerontology. 2019;65(3):216-228. doi: 10.1159/000492572. Epub 2018 Sep 10.
10
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.在 SUSTAIN 6 试验中,每周一次司美格鲁肽可降低 2 型糖尿病患者的心血管风险:基于性别、年龄和基线心血管风险特征的事后分析。
Cardiovasc Diabetol. 2019 Jun 6;18(1):73. doi: 10.1186/s12933-019-0871-8.

本文引用的文献

1
Trial of Lixisenatide in Early Parkinson's Disease.利西拉肽治疗早期帕金森病的试验。
N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323.
2
Prevalence of Cardiometabolic Diseases Among Racial and Ethnic Subgroups in Adults - Behavioral Risk Factor Surveillance System, United States, 2013-2021.2013 - 2021年美国成年人种族和族裔亚组中心血管代谢疾病的患病率 - 行为危险因素监测系统
MMWR Morb Mortal Wkly Rep. 2024 Jan 25;73(3):51-56. doi: 10.15585/mmwr.mm7303a1.
3
The epidemiology of Parkinson's disease.帕金森病的流行病学。
Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8.
4
Longitudinal study of the inverse relationship between Parkinson's disease and cancer in Korea.韩国帕金森病与癌症之间负相关关系的纵向研究。
NPJ Parkinsons Dis. 2023 Jul 22;9(1):116. doi: 10.1038/s41531-023-00562-5.
5
Impact of Parkinson's Disease on Functional Mobility at Different Stages.帕金森病在不同阶段对功能性活动能力的影响。
Front Aging Neurosci. 2022 Jun 15;14:935841. doi: 10.3389/fnagi.2022.935841. eCollection 2022.
6
Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender.帕金森病与癌症:关于生活习惯、基因变异及性别的影响的系统评价与荟萃分析
Aging (Albany NY). 2022 Mar 5;14(5):2148-2173. doi: 10.18632/aging.203932.
7
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.SCORE2 风险预测算法:用于评估欧洲人群 10 年心血管疾病风险的新模型。
Eur Heart J. 2021 Jul 1;42(25):2439-2454. doi: 10.1093/eurheartj/ehab309.
8
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.心力衰竭的通用定义和分类:美国心力衰竭学会、欧洲心脏病学会心力衰竭协会、日本心力衰竭学会和心力衰竭通用定义写作委员会的报告:得到加拿大心力衰竭学会、印度心力衰竭协会、澳大利亚和新西兰心脏病学会以及中国心力衰竭协会的认可。
Eur J Heart Fail. 2021 Mar;23(3):352-380. doi: 10.1002/ejhf.2115. Epub 2021 Mar 3.
9
Association of Parkinson Disease With Risk of Cardiovascular Disease and All-Cause Mortality: A Nationwide, Population-Based Cohort Study.帕金森病与心血管疾病风险及全因死亡率的关联:一项基于全国人口的队列研究。
Circulation. 2020 Apr 7;141(14):1205-1207. doi: 10.1161/CIRCULATIONAHA.119.044948. Epub 2020 Apr 6.
10
Trends in the incidence and prevalence of Parkinson's disease in Korea: a nationwide, population-based study.韩国帕金森病发病率和患病率的趋势:一项全国性、基于人群的研究。
BMC Geriatr. 2019 Nov 21;19(1):320. doi: 10.1186/s12877-019-1332-7.